help button home button Endocrine Society Endocrine Reviews
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heinlein, C. A.
Right arrow Articles by Chang, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heinlein, C. A.
Right arrow Articles by Chang, C.
Right arrowPubmed/NCBI databases
*Genetics Home Reference
Endocrine Reviews 23 (2): 175-200
Copyright © 2002 by The Endocrine Society

Androgen Receptor (AR) Coregulators: An Overview

Cynthia A. Heinlein and Chawnshang Chang

George Whipple Laboratory for Cancer Research, Departments of Pathology, Urology, and Radiation Oncology, University of Rochester, Rochester, New York 14642

Correspondence: Address all correspondence and requests for reprints to: Chawnshang Chang, Ph.D., George Whipple Laboratory for Cancer Research, Department of Pathology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, New York 14642. E-mail: chang{at}urmc.rochester.edu

The biological action of androgens is mediated through the androgen receptor (AR). Androgen-bound AR functions as a transcription factor to regulate genes involved in an array of physiological processes, most notably male sexual differentiation and maturation, and the maintenance of spermatogenesis. The transcriptional activity of AR is affected by coregulators that influence a number of functional properties of AR, including ligand selectivity and DNA binding capacity. As the promoter of target genes, coregulators participate in DNA modification, either directly through modification of histones or indirectly by the recruitment of chromatin-modifying complexes, as well as functioning in the recruitment of the basal transcriptional machinery. Aberrant coregulator activity due to mutation or altered expression levels may be a contributing factor in the progression of diseases related to AR activity, such as prostate cancer. AR demonstrates distinct differences in its interaction with coregulators from other steroid receptors due to differences in the functional interaction between AR domains, possibly resulting in alterations in the dynamic interactions between coregulator complexes.




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
D. J. van de Wijngaart, H. J. Dubbink, M. Molier, C. de Vos, J. Trapman, and G. Jenster
Functional Screening of FxxLF-Like Peptide Motifs Identifies SMARCD1/BAF60a as an Androgen Receptor Cofactor that Modulates TMPRSS2 Expression
Mol. Endocrinol., November 1, 2009; 23(11): 1776 - 1786.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. L. Nalam, C. Andreu-Vieyra, R. E. Braun, H. Akiyama, and M. M. Matzuk
Retinoblastoma Protein Plays Multiple Essential Roles in the Terminal Differentiation of Sertoli Cells
Mol. Endocrinol., November 1, 2009; 23(11): 1900 - 1913.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. K. Waltering, M. A. Helenius, B. Sahu, V. Manni, M. J. Linja, O. A. Janne, and T. Visakorpi
Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens
Cancer Res., October 15, 2009; 69(20): 8141 - 8149.
[Abstract] [Full Text] [PDF]


Home page
Therapeutic Advances in UrologyHome page
A. Aversa, R. Bruzziches, D. Francomano, M. Natali, and A. Lenzi
Testosterone and phosphodiesterase type-5 inhibitors: new strategy for preventing endothelial damage in internal and sexual medicine?
Therapeutic Advances in Urology, October 1, 2009; 1(4): 179 - 197.
[Abstract] [PDF]


Home page
EndocrinologyHome page
H. E. MacLean and D. J. Handelsman
Unraveling Androgen Action in Muscle: Genetic Tools Probing Cellular Mechanisms
Endocrinology, August 1, 2009; 150(8): 3437 - 3439.
[Full Text] [PDF]


Home page
Nucleic Acids ResHome page
F. Jin and J. D. Fondell
A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression
Nucleic Acids Res., August 1, 2009; 37(14): 4826 - 4838.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. V. Heemers, K. M. Regan, L. J. Schmidt, S. K. Anderson, K. V. Ballman, and D. J. Tindall
Androgen Modulation of Coregulator Expression in Prostate Cancer Cells
Mol. Endocrinol., April 1, 2009; 23(4): 572 - 583.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R.-S. Wang, S. Yeh, C.-R. Tzeng, and C. Chang
Androgen Receptor Roles in Spermatogenesis and Fertility: Lessons from Testicular Cell-Specific Androgen Receptor Knockout Mice
Endocr. Rev., April 1, 2009; 30(2): 119 - 132.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. T. H. Yeh
SUMOylation and De-SUMOylation: Wrestling with Life's Processes
J. Biol. Chem., March 27, 2009; 284(13): 8223 - 8227.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Fu, J. Jiang, J. Li, S. Wang, G. Shi, Q. Feng, E. White, J. Qin, and J. Wong
Deleted in Breast Cancer 1, a Novel Androgen Receptor (AR) Coactivator That Promotes AR DNA-binding Activity
J. Biol. Chem., March 13, 2009; 284(11): 6832 - 6840.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. E. Rosenblatt and K. L. Burnstein
Inhibition of Androgen Receptor Transcriptional Activity as a Novel Mechanism of Action of Arsenic
Mol. Endocrinol., March 1, 2009; 23(3): 412 - 421.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
M. Li, H. Schatten, and Q.-Y. Sun
Androgen receptor's destiny in mammalian oocytes: a new hypothesis
Mol. Hum. Reprod., March 1, 2009; 15(3): 149 - 154.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Snoek, H. Cheng, K. Margiotti, L. A. Wafa, C. A. Wong, E. C. Wong, L. Fazli, C. C. Nelson, M. E. Gleave, and P. S. Rennie
In vivo Knockdown of the Androgen Receptor Results in Growth Inhibition and Regression of Well-Established, Castration-Resistant Prostate Tumors
Clin. Cancer Res., January 1, 2009; 15(1): 39 - 47.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H.-Y. Kang, C.-R. Shyr, C.-K. Huang, M.-Y. Tsai, H. Orimo, P.-C. Lin, C. Chang, and K.-E. Huang
Altered TNSALP Expression and Phosphate Regulation Contribute to Reduced Mineralization in Mice Lacking Androgen Receptor
Mol. Cell. Biol., December 15, 2008; 28(24): 7354 - 7367.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
D. J Kojetin, T. P Burris, E. V Jensen, and S. A Khan
Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor
Endocr. Relat. Cancer, December 1, 2008; 15(4): 851 - 870.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. Zhao, J. Pan, X. Wang, Y. Wu, W. A. Bauman, and C. P. Cardozo
Expression of the Muscle Atrophy Factor Muscle Atrophy F-Box Is Suppressed by Testosterone
Endocrinology, November 1, 2008; 149(11): 5449 - 5460.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. Song, H. Wang, T. L. Krebs, S.-J. Kim, and D. Danielpour
Androgenic Control of Transforming Growth Factor-{beta} Signaling in Prostate Epithelial Cells through Transcriptional Suppression of Transforming Growth Factor-{beta} Receptor II
Cancer Res., October 1, 2008; 68(19): 8173 - 8182.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Dai, D. Ngo, J. Jacob, L. W. Forman, and D. V. Faller
Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes
Carcinogenesis, September 1, 2008; 29(9): 1725 - 1733.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Bingham and V. Viau
Neonatal Gonadectomy and Adult Testosterone Replacement Suggest an Involvement of Limbic Arginine Vasopressin and Androgen Receptors in the Organization of the Hypothalamic-Pituitary-Adrenal Axis
Endocrinology, July 1, 2008; 149(7): 3581 - 3591.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. A. Link, S. Balasubramaniam, A. Sharma, C. E.S. Comstock, S. Godoy-Tundidor, N. Powers, K. H. Cao, A. Haelens, F. Claessens, M. P. Revelo, et al.
Targeting the BAF57 SWI/SNF Subunit in Prostate Cancer: A Novel Platform to Control Androgen Receptor Activity
Cancer Res., June 15, 2008; 68(12): 4551 - 4558.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Bai and E. M. Wilson
Epidermal Growth Factor-Dependent Phosphorylation and Ubiquitinylation of MAGE-11 Regulates Its Interaction with the Androgen Receptor
Mol. Cell. Biol., March 15, 2008; 28(6): 1947 - 1963.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Chen, K. C. Ahn, N. A. Gee, M. I. Ahmed, A. J. Duleba, L. Zhao, S. J. Gee, B. D. Hammock, and B. L. Lasley
Triclocarban Enhances Testosterone Action: A New Type of Endocrine Disruptor?
Endocrinology, March 1, 2008; 149(3): 1173 - 1179.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Bai, G. Grossman, L. Yuan, B. A. Lessey, F. S. French, S. L. Young, and E. M. Wilson
Hormone control and expression of androgen receptor coregulator MAGE-11 in human endometrium during the window of receptivity to embryo implantation
Mol. Hum. Reprod., February 1, 2008; 14(2): 107 - 116.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P.-H. Chen, Y.-P. Tsao, C.-C. Wang, and S.-L. Chen
Nuclear receptor interaction protein, a coactivator of androgen receptors (AR), is regulated by AR and Sp1 to feed forward and activate its own gene expression through AR protein stability
Nucleic Acids Res., January 17, 2008; 36(1): 51 - 66.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
O. E Chausiaux, M. H Abel, F. O Baxter, W. T Khaled, P. J.I Ellis, H. M Charlton, and N. A Affara
Hypogonadal Mouse, a Model to Study the Effects of the Endogenous Lack of Gonadotropins on Apoptosis
Biol Reprod, January 1, 2008; 78(1): 77 - 90.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Peng, C. X. Li, F. Chen, Z. Wang, M. Ligr, J. Melamed, J. Wei, W. Gerald, M. Pagano, M. J. Garabedian, et al.
Stimulation of Prostate Cancer Cellular Proliferation and Invasion by the Androgen Receptor Co-Activator ARA70
Am. J. Pathol., January 1, 2008; 172(1): 225 - 235.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. V. Heemers and D. J. Tindall
Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex
Endocr. Rev., December 1, 2007; 28(7): 778 - 808.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
J. S. Rocha, M. S. Bonkowski, L. R. Franca, and A. Bartke
Mild Calorie Restriction Does Not Affect Testosterone Levels and Testicular Gene Expression in Mutant Mice
Experimental Biology and Medicine, September 1, 2007; 232(8): 1050 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
N. K. Mukhopadhyay, B. Cinar, L. Mukhopadhyay, M. Lutchman, A. S. Ferdinand, J. Kim, L. W. K. Chung, R. M. Adam, S. K. Ray, A. B. Leiter, et al.
The Zinc Finger Protein Ras-Responsive Element Binding Protein-1 Is a Coregulator of the Androgen Receptor: Implications for the Role of the Ras Pathway in Enhancing Androgenic Signaling in Prostate Cancer
Mol. Endocrinol., September 1, 2007; 21(9): 2056 - 2070.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Harada, R. Yasunaga, Y. Higashimura, R. Yamaji, K. Fujimoto, J. Moss, H. Inui, and Y. Nakano
Glyceraldehyde-3-phosphate Dehydrogenase Enhances Transcriptional Activity of Androgen Receptor in Prostate Cancer Cells
J. Biol. Chem., August 3, 2007; 282(31): 22651 - 22661.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
L. Leotoing, M. Manin, D. Monte, S. Baron, Y. Communal, C. Lours, G. Veyssiere, L. Morel, and C. Beaudoin
Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation
J. Mol. Endocrinol., August 1, 2007; 39(2): 151 - 162.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. Dai, D. Ngo, L. W. Forman, D. C. Qin, J. Jacob, and D. V. Faller
Sirtuin 1 Is Required for Antagonist-Induced Transcriptional Repression of Androgen-Responsive Genes by the Androgen Receptor
Mol. Endocrinol., August 1, 2007; 21(8): 1807 - 1821.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Kikuchi, C. Uchida, T. Hattori, T. Isobe, Y. Hiramatsu, K. Kitagawa, T. Oda, H. Konno, and M. Kitagawa
ARA54 is involved in transcriptional regulation of the cyclin D1 gene in human cancer cells
Carcinogenesis, August 1, 2007; 28(8): 1752 - 1758.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
L. Li, M. E Andersen, S. Heber, and Q. Zhang
Non-monotonic dose-response relationship in steroid hormone receptor-mediated gene expression
J. Mol. Endocrinol., May 1, 2007; 38(5): 569 - 585.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Vijayvargia, M. S. May, and J. D. Fondell
A Coregulatory Role for the Mediator Complex in Prostate Cancer Cell Proliferation and Gene Expression
Cancer Res., May 1, 2007; 67(9): 4034 - 4041.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Haelens, T. Tanner, S. Denayer, L. Callewaert, and F. Claessens
The Hinge Region Regulates DNA Binding, Nuclear Translocation, and Transactivation of the Androgen Receptor
Cancer Res., May 1, 2007; 67(9): 4514 - 4523.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A.-M. Moilanen, J. Hakkola, M. H. Vaarala, S. Kauppila, P. Hirvikoski, J. T. Vuoristo, R. J. Edwards, and T. K. Paavonen
Characterization of androgen-regulated expression of CYP3A5 in human prostate
Carcinogenesis, May 1, 2007; 28(5): 916 - 921.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. V. Heemers, T. J. Sebo, J. D. Debes, K. M. Regan, K. A. Raclaw, L. M. Murphy, A. Hobisch, Z. Culig, and D. J. Tindall
Androgen Deprivation Increases p300 Expression in Prostate Cancer Cells
Cancer Res., April 1, 2007; 67(7): 3422 - 3430.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. S. Nair, Z. Guo, J. M. Mueller, S. Koochekpour, Y. Qiu, R. R. Tekmal, R. Schule, H.-J. Kung, R. Kumar, and R. K. Vadlamudi
Proline-, Glutamic Acid-, and Leucine-Rich Protein-1/Modulator of Nongenomic Activity of Estrogen Receptor Enhances Androgen Receptor Functions through LIM-Only Coactivator, Four-and-a-Half LIM-Only Protein 2
Mol. Endocrinol., March 1, 2007; 21(3): 613 - 624.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Z. Yang, Y.-J. Chang, H. Miyamoto, S. Yeh, J. L. Yao, P. A. di Sant'Agnese, M.-Y. Tsai, and C. Chang
Suppression of Androgen Receptor Transactivation and Prostate Cancer Cell Growth by Heterogeneous Nuclear Ribonucleoprotein A1 via Interaction with Androgen Receptor Coregulator ARA54
Endocrinology, March 1, 2007; 148(3): 1340 - 1349.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
J. Hong, S. T. Kim, S. Tranguch, D. F Smith, and S. K Dey
Deficiency of co-chaperone immunophilin FKBP52 compromises sperm fertilizing capacity
Reproduction, February 1, 2007; 133(2): 395 - 403.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z. Yang, Y.-J. Chang, H. Miyamoto, J. Ni, Y. Niu, Z. Chen, Y.-L. Chen, J. L. Yao, P. A. di Sant'Agnese, and C. Chang
Transgelin Functions as a Suppressor via Inhibition of ARA54-Enhanced Androgen Receptor Transactivation and Prostate Cancer Cell Growth
Mol. Endocrinol., February 1, 2007; 21(2): 343 - 358.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
R. Jasavala, H. Martinez, J. Thumar, A. Andaya, A.-C. Gingras, J. K. Eng, R. Aebersold, D. K. Han, and M. E. Wright
Identification of Putative Androgen Receptor Interaction Protein Modules: Cytoskeleton and Endosomes Modulate Androgen Receptor Signaling in Prostate Cancer Cells
Mol. Cell. Proteomics, February 1, 2007; 6(2): 252 - 271.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Domanskyi, F.-P. Zhang, M. Nurmio, J. J. Palvimo, J. Toppari, and O. A. Janne
Expression and localization of androgen receptor-interacting protein-4 in the testis
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E513 - E522.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Ostrowski, J. E. Kuhns, J. A. Lupisella, M. C. Manfredi, B. C. Beehler, S. R. Krystek Jr., Y. Bi, C. Sun, R. Seethala, R. Golla, et al.
Pharmacological and X-Ray Structural Characterization of a Novel Selective Androgen Receptor Modulator: Potent Hyperanabolic Stimulation of Skeletal Muscle with Hypostimulation of Prostate in Rats
Endocrinology, January 1, 2007; 148(1): 4 - 12.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Seenundun and B. Robaire
Time-Dependent Rescue of Gene Expression by Androgens in the Mouse Proximal Caput Epididymidis-1 Cell Line after Androgen Withdrawal
Endocrinology, January 1, 2007; 148(1): 173 - 188.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. V. Gavrielides, A. M. Gonzalez-Guerrico, N. A. Riobo, and M. G. Kazanietz
Androgens Regulate Protein Kinase C{delta} Transcription and Modulate Its Apoptotic Function in Prostate Cancer Cells
Cancer Res., December 15, 2006; 66(24): 11792 - 11801.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
C. J Burd, L. M Morey, and K. E Knudsen
Androgen receptor corepressors and prostate cancer
Endocr. Relat. Cancer, December 1, 2006; 13(4): 979 - 994.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R.-S. Wang, S. Yeh, L.-M. Chen, H.-Y. Lin, C. Zhang, J. Ni, C.-C. Wu, P. A. di Sant'Agnese, K. L. deMesy-Bentley, C.-R. Tzeng, et al.
Androgen Receptor in Sertoli Cell Is Essential for Germ Cell Nursery and Junctional Complex Formation in Mouse Testes
Endocrinology, December 1, 2006; 147(12): 5624 - 5633.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Zhang, S. Yeh, Y.-T. Chen, C.-C. Wu, K.-H. Chuang, H.-Y. Lin, R.-S. Wang, Y.-J. Chang, C. Mendis-Handagama, L. Hu, et al.
Oligozoospermia with normal fertility in male mice lacking the androgen receptor in testis peritubular myoid cells
PNAS, November 21, 2006; 103(47): 17718 - 17723.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Cheng, R. Snoek, F. Ghaidi, M. E. Cox, and P. S. Rennie
Short Hairpin RNA Knockdown of the Androgen Receptor Attenuates Ligand-Independent Activation and Delays Tumor Progression
Cancer Res., November 1, 2006; 66(21): 10613 - 10620.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
L. Zhou, H. Wu, P. Lee, and Z. Wang
Roles of the androgen receptor cofactor p44 in the growth of prostate epithelial cells.
J. Mol. Endocrinol., October 1, 2006; 37(2): 283 - 300.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. V. Heemers, G. Verhoeven, and J. V. Swinnen
Androgen Activation of the Sterol Regulatory Element-Binding Protein Pathway: Current Insights
Mol. Endocrinol., October 1, 2006; 20(10): 2265 - 2277.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. R. Logan, L. Gaughan, S. R. C. McCracken, V. Sapountzi, H. Y. Leung, and C. N. Robson
Human PIRH2 Enhances Androgen Receptor Signaling through Inhibition of Histone Deacetylase 1 and Is Overexpressed in Prostate Cancer.
Mol. Cell. Biol., September 1, 2006; 26(17): 6502 - 6510.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. Kuwahara, A. Ikei, Y. Taguchi, Y. Tabuchi, N. Fujimoto, M. Obinata, S. Uesugi, and Y. Kurihara
PSPC1, NONO, and SFPQ Are Expressed in Mouse Sertoli Cells and May Function as Coregulators of Androgen Receptor-Mediated Transcription
Biol Reprod, September 1, 2006; 75(3): 352 - 359.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. J. Dubbink, R. Hersmus, A. C. W. Pike, M. Molier, A. O. Brinkmann, G. Jenster, and J. Trapman
Androgen Receptor Ligand-Binding Domain Interaction and Nuclear Receptor Specificity of FXXLF and LXXLL Motifs as Determined by L/F Swapping
Mol. Endocrinol., August 1, 2006; 20(8): 1742 - 1755.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. van de Wijngaart, M. E. van Royen, R. Hersmus, A. C. W. Pike, A. B. Houtsmuller, G. Jenster, J. Trapman, and H. J. Dubbink
Novel FXXFF and FXXMF Motifs in Androgen Receptor Cofactors Mediate High Affinity and Specific Interactions with the Ligand-binding Domain
J. Biol. Chem., July 14, 2006; 281(28): 19407 - 19416.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Carascossa, J. Gobinet, V. Georget, A. Lucas, E. Badia, A. Castet, R. White, J.-C. Nicolas, V. Cavailles, and S. Jalaguier
Receptor-Interacting Protein 140 Is a Repressor of the Androgen Receptor Activity
Mol. Endocrinol., July 1, 2006; 20(7): 1506 - 1518.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
S. Gao, H. Wang, P. Lee, J. Melamed, C. X Li, F. Zhang, H. Wu, L. Zhou, and Z. Wang
Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland.
J. Mol. Endocrinol., June 1, 2006; 36(3): 463 - 483.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H.-G. Yoon and J. Wong
The Corepressors Silencing Mediator of Retinoid and Thyroid Hormone Receptor and Nuclear Receptor Corepressor Are Involved in Agonist- and Antagonist-Regulated Transcription by Androgen Receptor
Mol. Endocrinol., May 1, 2006; 20(5): 1048 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. S. Lyons and K. L. Burnstein
Vav3, a Rho GTPase Guanine Nucleotide Exchange Factor, Increases during Progression to Androgen Independence in Prostate Cancer Cells and Potentiates Androgen Receptor Transcriptional Activity
Mol. Endocrinol., May 1, 2006; 20(5): 1061 - 1072.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. D. Federman
The Biology of Human Sex Differences
N. Engl. J. Med., April 6, 2006; 354(14): 1507 - 1514.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Li, J. Fu, C. Toumazou, H.-G. Yoon, and J. Wong
A Role of the Amino-Terminal (N) and Carboxyl-Terminal (C) Interaction in Binding of Androgen Receptor to Chromatin
Mol. Endocrinol., April 1, 2006; 20(4): 776 - 785.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. M. Hillier, J. C. Marquis, B. Zayas, J. S. Wishnok, R. G. Liberman, P. L. Skipper, S. R. Tannenbaum, J. M. Essigmann, and R. G. Croy
DNA adducts formed by a novel antitumor agent 11{beta}-dichloro in vitro and in vivo.
Mol. Cancer Ther., April 1, 2006; 5(4): 977 - 984.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Zheng, C. Cai, J. Omwancha, S.-Y. Chen, T. Baslan, and L. Shemshedini
SUMO-3 Enhances Androgen Receptor Transcriptional Activity through a Sumoylation-independent Mechanism in Prostate Cancer Cells
J. Biol. Chem., February 17, 2006; 281(7): 4002 - 4012.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. J. Burd, C. E. Petre, L. M. Morey, Y. Wang, M. P. Revelo, C. A. Haiman, S. Lu, C. M. Fenoglio-Preiser, J. Li, E. S. Knudsen, et al.
Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation
PNAS, February 14, 2006; 103(7): 2190 - 2195.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. K. Yang, J. H. Kim, H. Li, and M. R. Stallcup
Differential Use of Functional Domains by Coiled-coil Coactivator in Its Synergistic Coactivator Function with beta-Catenin or GRIP1
J. Biol. Chem., February 10, 2006; 281(6): 3389 - 3397.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. J. Asirvatham, M. Schmidt, B. Gao, and J. Chaudhary
Androgens Regulate the Immune/Inflammatory Response and Cell Survival Pathways in Rat Ventral Prostate Epithelial Cells
Endocrinology, January 1, 2006; 147(1): 257 - 271.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Chen, M. Nomura, H. Morinaga, E. Matsubara, T. Okabe, K. Goto, T. Yanase, H. Zheng, J. Lu, and H. Nawata
Modulation of Androgen Receptor Transactivation by FoxH1: A NEWLY IDENTIFIED ANDROGEN RECEPTOR COREPRESSOR
J. Biol. Chem., October 28, 2005; 280(43): 36355 - 36363.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
J. Igarashi-Migitaka, A. Takeshita, N. Koibuchi, S. Yamada, R. Ohtani-Kaneko, and K. Hirata
Differential expression of p160 steroid receptor coactivators in the rat testis and epididymis
Eur. J. Endocrinol., October 1, 2005; 153(4): 595 - 604.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. Li, C. N. Cavasotto, T. Cardozo, S. Ha, T. Dang, S. S. Taneja, S. K. Logan, and M. J. Garabedian
Androgen Receptor Mutations Identified in Prostate Cancer and Androgen Insensitivity Syndrome Display Aberrant ART-27 Coactivator Function
Mol. Endocrinol., September 1, 2005; 19(9): 2273 - 2282.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Ye, S. J. Han, S. Y. Tsai, F. J. DeMayo, J. Xu, M.-J. Tsai, and B. W. O'Malley
Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice
PNAS, July 5, 2005; 102(27): 9487 - 9492.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. Dong, H. Zhang, A. C. Gao, J. R. Marshall, and C. Ip
Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers
Mol. Cancer Ther., July 1, 2005; 4(7): 1047 - 1055.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H.-Y. Lin, Q. Xu, S. Yeh, R.-S. Wang, J. D. Sparks, and C. Chang
Insulin and Leptin Resistance With Hyperleptinemia in Mice Lacking Androgen Receptor
Diabetes, June 1, 2005; 54(6): 1717 - 1725.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T.-C. Tsai, Y.-L. Lee, W.-C. Hsiao, Y.-P. Tsao, and S.-L. Chen
NRIP, a Novel Nuclear Receptor Interaction Protein, Enhances the Transcriptional Activity of Nuclear Receptors
J. Biol. Chem., May 20, 2005; 280(20): 20000 - 20009.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H. Yuan, A. Gong, and C. Y.F. Young
Involvement of transcription factor Sp1 in quercetin-mediated inhibitory effect on the androgen receptor in human prostate cancer cells
Carcinogenesis, April 1, 2005; 26(4): 793 - 801.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W.-H. Yang and S. R Hammes
Xenopus laevis CYP17 Regulates Androgen Biosynthesis Independent of the Cofactor Cytochrome b5
J. Biol. Chem., March 18, 2005; 280(11): 10196 - 10201.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. A. Link, C. J. Burd, E. Williams, T. Marshall, G. Rosson, E. Henry, B. Weissman, and K. E. Knudsen
BAF57 Governs Androgen Receptor Action and Androgen-Dependent Proliferation through SWI/SNF
Mol. Cell. Biol., March 15, 2005; 25(6): 2200 - 2215.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Wang, K. Song, T. L. Sponseller, and D. Danielpour
Novel Function of Androgen Receptor-associated Protein 55/Hic-5 as a Negative Regulator of Smad3 Signaling
J. Biol. Chem., February 18, 2005; 280(7): 5154 - 5162.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C.-L. Hsu, Y.-L. Chen, H.-J. Ting, W.-J. Lin, Z. Yang, Y. Zhang, L. Wang, C.-T. Wu, H.-C. Chang, S. Yeh, et al.
Androgen Receptor (AR) NH2- and COOH-Terminal Interactions Result in the Differential Influences on the AR-Mediated Transactivation and Cell Growth
Mol. Endocrinol., February 1, 2005; 19(2): 350 - 361.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Umar, C. A. Berrevoets, N. M. Van, M. van Leeuwen, M. Verbiest, W. J. Kleijer, D. Dooijes, J. A. Grootegoed, S. L. S. Drop, and A. O. Brinkmann
Functional Analysis of a Novel Androgen Receptor Mutation, Q902K, in an Individual with Partial Androgen Insensitivity
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 507 - 515.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D.-Y. Lin, H.-I Fang, A.-H. Ma, Y.-S. Huang, Y.-S. Pu, G. Jenster, H.-J. Kung, and H.-M. Shih
Negative Modulation of Androgen Receptor Transcriptional Activity by Daxx
Mol. Cell. Biol., December 15, 2004; 24(24): 10529 - 10541.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Jung, R.-S. Kim, H.-J. Zhang, S.-J. Lee, and M.-H. Jeng
HOXB13 Induces Growth Suppression of Prostate Cancer Cells as a Repressor of Hormone-Activated Androgen Receptor Signaling
Cancer Res., December 15, 2004; 64(24): 9185 - 9192.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Zhu, M. Mazor, Y. Kawano, M. M. Walker, H. Y. Leung, K. Armstrong, J. Waxman, and R. M. Kypta
Analysis of Wnt Gene Expression in Prostate Cancer: Mutual Inhibition by WNT11 and the Androgen Receptor
Cancer Res., November 1, 2004; 64(21): 7918 - 7926.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
K. Steketee, A. C J Ziel-van der Made, H. A G M van der Korput, A. B Houtsmuller, and J. Trapman
A bioinformatics-based functional analysis shows that the specifically androgen-regulated gene SARG contains an active direct repeat androgen response element in the first intron
J. Mol. Endocrinol., October 1, 2004; 33(2): 477 - 491.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. J. Dubbink, R. Hersmus, C. S. Verma, H. A. G. M. van der Korput, C. A. Berrevoets, J. van Tol, A. C. J. Ziel-van der Made, A. O. Brinkmann, A. C. W. Pike, and J. Trapman
Distinct Recognition Modes of FXXLF and LXXLL Motifs by the Androgen Receptor
Mol. Endocrinol., September 1, 2004; 18(9): 2132 - 2150.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-C. Hu, S. Yeh, S.-D. Yeh, E. R. Sampson, J. Huang, P. Li, C.-L. Hsu, H.-J. Ting, H.-K. Lin, L. Wang, et al.
Functional Domain and Motif Analyses of Androgen Receptor Coregulator ARA70 and Its Differential Expression in Prostate Cancer
J. Biol. Chem., August 6, 2004; 279(32): 33438 - 33446.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y.-C. Hu, P.-H. Wang, S. Yeh, R.-S. Wang, C. Xie, Q. Xu, X. Zhou, H.-T. Chao, M.-Y. Tsai, and C. Chang
Subfertility and defective folliculogenesis in female mice lacking androgen receptor
PNAS, August 3, 2004; 101(31): 11209 - 11214.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Y. A. Elhaji, J. Hui Wu, B. Gottlieb, L. K. Beitel, C. Alvarado, G. Batist, and M. A. Trifiro
An Examination of How Different Mutations at Arginine 855 of the Androgen Receptor Result in Different Androgen Insensitivity Phenotypes
Mol. Endocrinol., August 1, 2004; 18(8): 1876 - 1886.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Powzaniuk, S. McElwee-Witmer, R. L. Vogel, T. Hayami, S. J. Rutledge, F. Chen, S.-i. Harada, A. Schmidt, G. A. Rodan, L. P. Freedman, et al.
The LATS2/KPM Tumor Suppressor Is a Negative Regulator of the Androgen Receptor
Mol. Endocrinol., August 1, 2004; 18(8): 2011 - 2023.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Cheng, D. Wang, Z. Wang, and E. T. H. Yeh
SENP1 Enhances Androgen Receptor-Dependent Transcription through Desumoylation of Histone Deacetylase 1
Mol. Cell. Biol., July 1, 2004; 24(13): 6021 - 6028.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson
Androgens and Bone
Endocr. Rev., June 1, 2004; 25(3): 389 - 425.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
L. Callewaert, G. Verrijdt, A. Haelens, and F. Claessens
Differential Effect of Small Ubiquitin-Like Modifier (SUMO)-ylation of the Androgen Receptor in the Control of Cooperativity on Selective Versus Canonical Response Elements
Mol. Endocrinol., June 1, 2004; 18(6): 1438 - 1449.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Liu, B. O. Kim, C. Kao, C. Jung, J. T. Dalton, and J. J. He
Tip110, the Human Immunodeficiency Virus Type 1 (HIV-1) Tat-interacting Protein of 110 kDa as a Negative Regulator of Androgen Receptor (AR) Transcriptional Activation
J. Biol. Chem., May 21, 2004; 279(21): 21766 - 21773.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Chang, Y.-T. Chen, S.-D. Yeh, Q. Xu, R.-S. Wang, F. Guillou, H. Lardy, and S. Yeh
Infertility with defective spermatogenesis and hypotestosteronemia in male mice lacking the androgen receptor in Sertoli cells
PNAS, May 4, 2004; 101(18): 6876 - 6881.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Centrella, T. L. McCarthy, W.-Z. Chang, D. C. Labaree, and R. B. Hochberg
Estren (4-Estren-3{alpha},17{beta}-diol) Is a Prohormone that Regulates Both Androgenic and Estrogenic Transcriptional Effects through the Androgen Receptor
Mol. Endocrinol., May 1, 2004; 18(5): 1120 - 1130.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Wang, T. S. Udayakumar, T. S. Vasaitis, A. M. Brodie, and J. D. Fondell
Mechanistic Relationship between Androgen Receptor Polyglutamine Tract Truncation and Androgen-dependent Transcriptional Hyperactivity in Prostate Cancer Cells
J. Biol. Chem., April 23, 2004; 279(17): 17319 - 17328.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. A. Heinlein and C. Chang
Androgen Receptor in Prostate Cancer
Endocr. Rev., April 1, 2004; 25(2): 276 - 308.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society